Year in Review: What Themes Emerged in Cancer Research in 2024?
Several themes emerged in cancer research in 2024, including FDA-approved first-in-class therapeutics, advances in cancer vaccines, and more.
Related Articles
AACR Outstanding Investigator shares work on integrative breast cancer subtypes – SABCS Meeting News
Christina Curtis, PhD, MSc, on Wednesday discussed processes that drive cancer progression across various disease stages and molecular subtypes.
Revumenib Combo Yields High Remission Rates in Relapsed/Refractory AML
The combination of revumenib plus decitabine/cedazuridine showed high rates of remission among patients with relapsed/refractory AML with KMT2Ar, NPM1mt, and NUP98r genetic alterations.
Now’s the time to discuss family health history
Knowing your family health history is important — and could ultimately be life-saving for you or a family member. Kari Thorsen, MS, CGC, is a…
Cannabidiol for Scan-Related Anxiety in Women With Advanced Breast Cancer
This randomized clinical trial investigates whether a single oral dose of cannabidiol improves scan-related anxiety in women with advanced breast cancer.
Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
A pooled analysis of 9548 HNC cases and 15,783 controls from the International Head and Neck Cancer Epidemiology consortium was conducted to assess the association…
Lurbinectedin Demonstrates Promise As Second-Line Option for Patients With Platinum-Sensitive Small Cell Lung Cancer
Retrospective analysis results demonstrated that lurbinectedin shows promise as a potential new second-line option for patients with platinum-sensitive small cell lung cancer who experience relapse…
Fox Chase Perioperative Care Team Enjoys a Lively Lunch to Celebrate the Season
Holiday happenings around Temple Health this year included a festive luncheon attended by members of the Perioperative Care team at Fox Chase Cancer Center.
Evaluating the Economic Impact of Novel Oncology Drug Coverage Through Patient Assistance Programs | JCO Oncology Practice
PURPOSEDespite a universal public health care system, Canadian oncology patients often enroll in patient assistance programs (PAPs) to access oncology drugs that are awaiting funding…
